{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:18:28Z","timestamp":1791091108787,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T10:02:08Z","timestamp":1397383328000},"page":"3187-3197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Assurance of neuroattenuation of a live vaccine against West Nile virus: A comprehensive study of neuropathogenesis after infection with chimeric WN\/DEN4\u039430 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Olga A.","family":"Maximova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Speicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff R.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa C.","family":"St. Claire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny R.","family":"Ragland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan R.","family":"Pare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashida M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CMR.00045-12","article-title":"West Nile virus: biology, transmission, and human infection","volume":"25","author":"Colpitts","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/NEN.0b013e3181b88114","article-title":"West Nile virus infections","volume":"68","author":"Gyure","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11908-011-0193-9","article-title":"West Nile virus neuroinvasive disease","volume":"13","author":"Debiasi","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"5448","key":"10.1016\/j.vaccine.2014.04.002_bib0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.002_bib0025","first-page":"1","article-title":"Surveillance for human West Nile virus disease\u2014United States, 1999\u20132008","volume":"59","author":"Lindsey","year":"2010","journal-title":"MMWR Surveill Summ"},{"issue":"14","key":"10.1016\/j.vaccine.2014.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMp1210537","article-title":"Unpredictable and difficult to control\u2014the adolescence of West Nile virus","volume":"367","author":"Petersen","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid1203.050782","article-title":"Cost-effectiveness of West Nile virus vaccination","volume":"12","author":"Zohrabian","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.002_bib0040","first-page":"139","article-title":"West Nile Virus: is a vaccine needed?","volume":"11","author":"Martina","year":"2010","journal-title":"Curr Opin Invest Drugs"},{"issue":"6098","key":"10.1016\/j.vaccine.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.337.6098.1030","article-title":"Public health. Outbreak pattern stymies vaccine work","volume":"337","author":"Kaiser","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.04.015","article-title":"Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?","volume":"99","author":"Beasley","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0055","series-title":"West Nile virus disease cases and deaths reported to CDC by year and clinical presentation","author":"CDC","year":"1999"},{"issue":"27","key":"10.1016\/j.vaccine.2014.04.002_bib0060","first-page":"510","article-title":"West Nile virus disease and other arboviral diseases\u2014United States, 2011","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0065","first-page":"1","article-title":"Estimated cumulative incidence of West Nile virus infection in US adults, 1999\u20132010","author":"Petersen","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.002_bib0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/imt.10.93","article-title":"Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus","volume":"3","author":"Beasley","year":"2011","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"De Filette","year":"2012","journal-title":"Vet Res"},{"issue":"17","key":"10.1016\/j.vaccine.2014.04.002_bib0080","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/jiq003","article-title":"Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults","volume":"203","author":"Biedenbender","year":"2011","journal-title":"J Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2014.04.002_bib0090","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.vaccine.2012.08.063","article-title":"Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults \u226550 years of age","volume":"30","author":"Dayan","year":"2012","journal-title":"Vaccine"},{"issue":"40-41","key":"10.1016\/j.vaccine.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/523650","article-title":"A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial","volume":"196","author":"Martin","year":"2007","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2014.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1128\/CVI.00119-09","article-title":"Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys","volume":"16","author":"Lieberman","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0115","series-title":"Vaccines IR seminar","first-page":"33","author":"Pasteur","year":"2009"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.002_bib0120","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vbz.2005.5.1","article-title":"Infectivity of West Nile\/dengue chimeric viruses for West Nile and dengue mosquito vectors","volume":"5","author":"Hanley","year":"2005","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2014.04.002_bib0135","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2013.07.064","article-title":"The live attenuated chimeric vaccine rWN\/DEN4Delta30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers","volume":"31","author":"Durbin","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.002_bib0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.002_bib0145","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.00172-08","article-title":"Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates","volume":"82","author":"Maximova","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0150","series-title":"Proposed replacement of Annex 1 of WHO Technical Report Series, No 932","article-title":"Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated)","author":"WHO","year":"2011"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0155","series-title":"Replacement of WHO TRS No 910 (Annex 3)","article-title":"Recommendations to assure the quality, safety and efficacy of Japanese encephalitis vaccine (live, attenuated) for human use","author":"WHO","year":"2012"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.002_bib0160","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1369\/jhc.2009.954180","article-title":"Cellular inflammatory response to flaviviruses in the central nervous system of a primate host","volume":"57","author":"Maximova","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0165","series-title":"Primate brain maps: structure of the macaque brain","author":"Martin","year":"2000"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.002_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ilar.49.2.220","article-title":"Macaque models of human infectious disease","volume":"49","author":"Gardner","year":"2008","journal-title":"ILAR J"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.002_bib0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0300985810372507","article-title":"Flavivirus encephalitis: pathological aspects of mouse and other animal models","volume":"47","author":"Kimura","year":"2010","journal-title":"Vet Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.002_bib0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/ars.2010.3241","article-title":"Nonhuman primate models of human immunology","volume":"14","author":"Messaoudi","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.vaccine.2014.04.002_bib0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","article-title":"A neurotropic virus isolated from the blood of a native of Uganda","volume":"20","author":"Smithburn","year":"1940","journal-title":"Am J Trop Med"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.002_bib0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3181\/00379727-77-18884","article-title":"Isolation from human sera in Egypt of a virus apparently identical to West Nile virus","volume":"77","author":"Melnick","year":"1951","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1-2","key":"10.1016\/j.vaccine.2014.04.002_bib0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01314128","article-title":"Study on West Nile virus persistence in monkeys","volume":"75","author":"Pogodina","year":"1983","journal-title":"Arch Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.002_bib0200","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3201\/eid0911.030226","article-title":"West Nile virus infection in nonhuman primate breeding colony, concurrent with human epidemic, southern Louisiana","volume":"9","author":"Ratterree","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.002_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/381461","article-title":"Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection","volume":"189","author":"Ratterree","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.002_bib0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2006.06.033","article-title":"Baboon model for West Nile virus infection and vaccine evaluation","volume":"355","author":"Wolf","year":"2006","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.002_bib0215","doi-asserted-by":"crossref","first-page":"e15514","DOI":"10.1371\/journal.pone.0015514","article-title":"Immune response to the West Nile virus in aged non-human primates","volume":"5","author":"Wertheimer","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.002_bib0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00005072-195610000-00007","article-title":"Neuropathology of experimental West Nile virus infection in monkeys","volume":"15","author":"Manuelidis","year":"1956","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.002_bib0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/oxfordjournals.aje.a120713","article-title":"Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses","volume":"85","author":"Nathanson","year":"1967","journal-title":"Am J Epidemiol"},{"issue":"22","key":"10.1016\/j.vaccine.2014.04.002_bib0230","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2014.04.002_bib0235","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.humpath.2004.04.008","article-title":"Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis","volume":"35","author":"Guarner","year":"2004","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.002_bib0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.20959","article-title":"West Nile virus neuroinvasive disease","volume":"60","author":"Davis","year":"2006","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.002_bib0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ncpneuro0176","article-title":"West Nile virus meningoencephalitis","volume":"2","author":"Debiasi","year":"2006","journal-title":"Nat Clin Pract Neurol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:35:51Z","timestamp":1565343351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":49,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14005040"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assurance of neuroattenuation of a live vaccine against West Nile virus: A comprehensive study of neuropathogenesis after infection with chimeric WN\/DEN4\u039430 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}